Home
Conditions
Hypersensitivity, Immediate

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,736 public trials 631 recruiting studies

Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma

NCT00994175

Conditions: Airflow Obstruction, Airway Inflammation, Asthma, +9 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

INOVA Fairfax Hospital Falls Church, Virginia, United States

View Trial Details

Completed

Efficacy of AC-170 for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (CAC) Model

NCT01332188

Conditions: Allergic Conjunctivitis, Conjunctival Diseases, Conjunctivitis, +5 more
Locations: Ora, Inc. Andover, Massachusetts, United States

View Trial Details

Completed

Exploring a Cessation Intervention for Smokers

NCT01728038

Conditions: Asthma, Bronchial Diseases, Bronchiolitis, +19 more
Locations: Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

View Trial Details

Completed

Cetirizine Placebo Controlled Study For Perennial Allergic Rhinitis

NCT00490204

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations: GSK Investigational Site Chiba, Japan

GSK Investigational Site Fukuoka, Japan

GSK Investigational Site Fukuoka, Japan

GSK Investigational Site Fukuoka, Japan

View all 28 locations

View Trial Details

Completed

Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

NCT01859988

Conditions: Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations: Birmingham, Alabama, United States

Mobile, Alabama, United States

Tucson, Arizona, United States

Bakersfield, California, United States

View all 84 locations

View Trial Details

Completed

Eosinophilic Esophagitis Databank

NCT01323803

Conditions: Digestive System Diseases, Eosinophilia, Eosinophilic Esophagitis, +10 more
Locations: Arkansas Children's Hospital Little Rock, Arkansas, United States

National Jewish Health Denver, Colorado, United States

Johns Hopkins University Baltimore, Maryland, United States

Mount Sinai School of Medicine New York, United States

View Trial Details

Completed

Efficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells Syndrome

NCT00465985

Conditions: Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +18 more
Locations: Novartis Investigative Site San Francisco, California, United States

Novartis Investigative Site Chicago, Illinois, United States

Novartis Investigative Site Madison, Wisconsin, United States

Novartis Investigative Site Le Kremlin-Bicêtre, France

View Trial Details

Completed

Pilot Study of How Children With Asthma Exacerbations Metabolize Prednisone

NCT01260623

Conditions: Asthma, Asthma Exacerbation, Bronchial Diseases, +7 more
Locations: Pediatric Emergency Department, Children's Hospital, London Health Sciences Centre London, Ontario, Canada

View Trial Details

Completed

In-Use Test With a Cosmetic Product

NCT03252730

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
Locations: SIT Skin Investigation and Technology Hamburg GmbH Hamburg, Germany

View Trial Details

Completed

Texting Atopic Dermatitis Patients to Optimize Learning and EASI Scores

NCT02779426

Conditions: Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations: Columbia University Medical Center, Department of Dermatology New York, United States

View Trial Details

Hypersensitivity, Immediate

Hypersensitivity, Immediate trial results

Related conditions